Development of FDA-regulated medical products : prescription drugs, biologics, and medical devices

LDR 01626fam a2200421 a 4500
001 004346250
003 MiAaHDL
005 20240704000000.0
006 m d
007 cr bn ---auaua
008 031117s2003 wiu b 001 0 eng
010 ⊔ ⊔ ‡a2003023464
020 ⊔ ⊔ ‡a9781621980438 ‡q(electronic bk.)
020 ⊔ ⊔ ‡a0873896130 ‡q(hardcover, case bound)
035 ⊔ ⊔ ‡a(MiU)990043462500106381
035 ⊔ ⊔ ‡asdr-miu.990043462500106381
035 ⊔ ⊔ ‡z(MiU)MIU01000000000000004346250-goog
035 ⊔ ⊔ ‡a(OCoLC)244128624
035 ⊔ ⊔ ‡a(III)iiio42471576
035 ⊔ ⊔ ‡9(SH)ACD3821
035 ⊔ ⊔ ‡z(MiU)Aleph004346250
040 ⊔ ⊔ ‡aDLC ‡cDLC
042 ⊔ ⊔ ‡apcc
043 ⊔ ⊔ ‡an-us---
050 0 0 ‡aRA401.5 ‡b.W48 2003
082 0 0 ‡a615/.19 ‡222
100 1 ⊔ ‡aWhitmore, Elaine.
245 1 0 ‡aDevelopment of FDA-regulated medical products : ‡bprescription drugs, biologics, and medical devices / ‡cElaine Whitmore.
250 ⊔ ⊔ ‡a2nd ed.
260 ⊔ ⊔ ‡aMilwaukee, Wis. : ‡bASQ Quality Press, ‡c2003.
300 ⊔ ⊔ ‡axv, 159 p. ; ‡c24 cm.
500 ⊔ ⊔ ‡aPreviously published under the title: Product development planning for health care products regulated by the FDA.
504 ⊔ ⊔ ‡aIncludes bibliographical references and index.
538 ⊔ ⊔ ‡aMode of access: Internet.
610 1 0 ‡aUnited States. ‡bFood and Drug Administration
650 ⊔ 2 ‡aDrugs, Investigational ‡xstandards ‡zUnited States.
650 ⊔ 2 ‡aDrug Approval ‡zUnited States.
650 ⊔ 0 ‡aNew products ‡xStandards ‡zUnited States.
650 ⊔ 0 ‡aDrug approval ‡zUnited States.
700 1 ⊔ ‡aWhitmore, Elaine. ‡tProduct development planning for health care products regulated by the FDA.
710 2 ⊔ ‡aKnovel (Firm)
899 ⊔ ⊔ ‡a39015059955909
CID ⊔ ⊔ ‡a004346250
DAT 0 ⊔ ‡a20131022153621.0 ‡b20240704000000.0
DAT 1 ⊔ ‡a20240704120241.0 ‡b2024-07-05T07:15:12Z
DAT 2 ⊔ ‡a2020-09-19T17:30:03Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990043462500106381 ‡aMiU ‡bSDR ‡cMIU ‡f004346250 ‡pmdp.39015059955909 ‡sMIU ‡1990043462500106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20240705 ‡sgoogle ‡umdp.39015059955909 ‡y2003 ‡ric ‡qbib ‡tUS bib date1 >= 1929